The primary objective of this study is to determine the influence of morphine dosage (2.5 mg vs 7.5 mg) on the percentage of patients with a rated NRS of >= 4 during an painful and unavoidable intervention. The secondary objectives are to…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
Patiënten op de ICU, zowel electief als niet electief opgenomen
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The percentage of patients with a NRS of >= 4 during intervention (2.5 mg versus
7.5 mg morphine)
Secondary outcome
- The mean NRS during an intervention (2.5 mg versus 7.5 mg morphine)
- The mean NRS during an intervention (2.5 versus 7.5 mg morphine) corrected
for baseline NRS
- The percentage of patients with at least one NRS-score of >= 4 at rest during
ICU stay
- The mean NRS per patient in rest during ICU stay
- The percentage of patients with a NRS of >= 6 during intervention (2.5 mg
versus 7.5 mg morphine)
- Pharmacokinetic parameters of morphine (volumes of distribution and clearance
values)
- Pharmacodynamic parameters of morphine (EC50 etc)
- Covariates for the PK/PD of morphine (body weight, age, renal function
(ureum, creatinin concentrations and creatinin clearance), liver function,
diagnose, Sequential Organ Failure Assessment (SOFA) scores, DNA
polymorphisms (µ-opioid receptor, COMT etc) and perioperative endorphins and
stress hormones (epinephrine and norepinephrine), level of
sedation and/or concentration of sedative (propofol).
- Safety and other measures (nausea, constipation, respiratory depression,
length of ICU and hospital stay, duration of ventilation, hallucinations,
delirium, Glascow Coma Scale, endorphins, stress hormones
(epinephrine, norepinephrine and/or cortisol), liver function
tests and renal function) of the analgesics (morphine and
acetaminophen) used for intervention related pain as well as pain titration
protocol for pain control in rest.
Background summary
In 2006, in the Intensive Care Unit (ICU) of the St. Antonius Hospital an
analgesia improvement program has been implemented. This program consisted of
training of ICU nurses and intensivists using a hospital based standardized
pain protocol, and three times daily mandatory measurements of pain levels in
rest, rated by the patient himself whenever possible or otherwise by the
attending nurse. This program has resulted in a reduction of severe pain levels
(NRS>=4) in ICU patients in rest from 41% to 22%. In order to further reduce
this percentage, a pain titration protocol is introduced in 2007. As no
attention has yet been paid to intervention-related pain levels in these
patients, in this prospective study pain control will be studied using
different analgesic dosages of morphine around unavoidable painful
interventions within a pain titration protocol for pain control in rest.
Study objective
The primary objective of this study is to determine the influence of morphine
dosage (2.5 mg vs 7.5 mg) on the percentage of patients with a rated NRS of >= 4
during an painful and unavoidable intervention.
The secondary objectives are to evaluate NRS scores, safety and other aspects
of both the intervention related pain protocol (morphine 2.5 mg vs 7.5 mg) as
well as the standard pain titration protocol aiming at pain control in rest
(paracetamol and morphine), such as nausea, constipation, respiratory
depression, length of ICU and hospital stay, duration of ventilation,
hallucinations, delirium, Glascow Coma Scale, endorphins, stress hormones
(epinephrine, norepinephrine and/or cortisol), liver function tests and renal
function. Additionally, a population pharmacokinetic and pharmacodynamic model
of morphine and its metabolites will be developed using population
pharmacokinetics and/or pharmacodynamics (PK/PD) modelling and covariate
analysis in order to develop rational individualized dosing schemes for
morphine in ICU patients. Whenever possible the level of sedation or
concentration of sedative will be incorporated in the model leading to an
analgo-sedative model. Studied covariates will include body weight, age, renal
function (ureum, creatinin concentrations and creatinin clearance), liver
function, diagnose, Sequential Organ Failure Assessment (SOFA) scores, DNA
polymorphisms (µ-opioid receptor, COMT etc) and (perioperative) endorphins and
stress hormones (epinephrine, norepinephrine and/or cortisol).
Study design
Prospective, randomized, double blind, clinical trial
Intervention
150 patients will be randomized into two groups, one group will be given 2.5 mg
morphine and the other group will be given 7.5 mg morphine, half an hour before
the intervention (turning of the patient) Before, during and after the
intervention, the patients will be asked to rate the pain using NRS. When the
patient is not capable to communicate verbally, the pain ratings are scored by
the attending nurse using NRS. For basic pain relief, a standard pain titration
protocol is used in all patients, which is current practice in the ICU since
2007.
Study burden and risks
Participation in this study has minimal burden and risks for the patient, as
the two different doses of morphine (2.5 and 7.5 mg) administrated before the
unavoidable and painful intervention, both are within the therapeutic range.
In daily practice doses between 0 to 10 mg morphine are considered to be
standard, depending on the attending nurse and physician. Scoring NRS after
intervention may be a burden to the patient, because this may lead to a focus
of the patient to his pain.
The total amount of blood taken from the patient for this study is 28 ml per
day, with an additional 23 ml on the second day of admission to the ICU, and an
additional 19.5 ml for patients undergoing cardio- thoracic surgery before
admission to the ICU. These amounts are not expected to influence the recovery
of the patient. Moreover, all of the blood samples are taken from an existing
arterial line, so no invasive interventions are therefore needed. All the other
procedures (NRS scores, Pain titration protocol) are part of the standard care.
Koekoekslaan 1
3430EM
Nederland
Koekoekslaan 1
3430EM
Nederland
Listed location countries
Age
Inclusion criteria
Patients admitted to the ICU of the St. Antonius hospital, with the age of 18 years or older.
Exclusion criteria
- Pregnancy/ breastfeeding
- Language barrier
- Known morphine allergy
- Comatose patient (cooled)
- Patients who are suspected to be braindead
- Unintubated patients on the verge of intubation due to respiratory
insufficiency
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
EudraCT | EUCTR2007-003722-18-NL |
CCMO | NL18828.100.07 |